Vitrolife AB
STO:VITR

Watchlist Manager
Vitrolife AB Logo
Vitrolife AB
STO:VITR
Watchlist
Price: 223.4 SEK -2.27% Market Closed
Market Cap: 30.2B SEK
Have any thoughts about
Vitrolife AB?
Write Note

Vitrolife AB
Effect of Foreign Exchange Rates

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vitrolife AB
Effect of Foreign Exchange Rates Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Effect of Foreign Exchange Rates CAGR 3Y CAGR 5Y CAGR 10Y
Vitrolife AB
STO:VITR
Effect of Foreign Exchange Rates
-kr58m
CAGR 3-Years
-74%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Effect of Foreign Exchange Rates
-kr10.8m
CAGR 3-Years
-62%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Effect of Foreign Exchange Rates
-kr2.1m
CAGR 3-Years
-212%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Probi AB
STO:PROB
Effect of Foreign Exchange Rates
-kr1.1m
CAGR 3-Years
50%
CAGR 5-Years
-128%
CAGR 10-Years
N/A
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Effect of Foreign Exchange Rates
-kr90m
CAGR 3-Years
-134%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
BioArctic AB
STO:BIOA B
Effect of Foreign Exchange Rates
-kr10.1m
CAGR 3-Years
-95%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Vitrolife AB
Glance View

Market Cap
30.2B SEK
Industry
Biotechnology

Vitrolife AB engages in the development, manufacture, and sale of products and systems for the preparation, cultivation, and storage of human cells, tissue, and organs. The company is headquartered in Goeteborg, Vastra Gotalands and currently employs 427 full-time employees. The company went IPO on 2001-06-26. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. The company also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The firm is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.

VITR Intrinsic Value
140.46 SEK
Overvaluation 37%
Intrinsic Value
Price

See Also

What is Vitrolife AB's Effect of Foreign Exchange Rates?
Effect of Foreign Exchange Rates
-58m SEK

Based on the financial report for Sep 30, 2024, Vitrolife AB's Effect of Foreign Exchange Rates amounts to -58m SEK.

What is Vitrolife AB's Effect of Foreign Exchange Rates growth rate?
Effect of Foreign Exchange Rates CAGR 3Y
-74%

The average annual Effect of Foreign Exchange Rates growth rates for Vitrolife AB have been -74% over the past three years .

Back to Top